Coaching to improve treatment adherence in thalassemia patients
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests whether motivational interviewing — a type of coaching that helps you stay on track with your treatment — can improve how well you stick to your iron chelation therapy and boost your confidence in managing thalassemia. If you join, you'll have one-on-one talks with a trained coach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You have been diagnosed with beta-thalassemia major and receive regular blood transfusions.
- You have been taking iron chelation therapy (medicine to remove extra iron) for at least 6 months.
- You are comfortable communicating in Arabic or English.
- You are able to attend study sessions and fill out questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if certain drugs can safely increase fetal hemoglobin (a type of hemoglobin that helps carry oxygen) in people with beta thalassemia major. It may offer a new way to manage the condition and reduce the need for transfusions.
This trial studies an investigational medicine in adults with beta thalassemia intermedia (including non-transfusion dependent thalassemia). The goal is to see how well the treatment works and how safe it is for people whose hemoglobin runs in a certain range.
This study tests an investigational oral medication (SNH-119014) in adults with non-transfusion-dependent thalassemia, which means they have anemia but don't need regular transfusions. It aims to see if the drug can safely help increase hemoglobin levels and improve symptoms.
This study tests a special system (Hemanext One) that stores red blood cells with less oxygen, to see if it helps people with thalassemia who need regular transfusions. It may reduce side effects or improve how well the transfusions work.
This early-phase trial tests a new way to restore working blood-making cells using your own stem cells for people with transfusion-dependent beta thalassemia major. The goal is to improve safety and blood results, and possibly reduce problems from the disease.
This trial tests a one-time gene therapy using your own blood stem cells to treat severe beta-thalassemia. It may help you stop needing regular blood transfusions.
Hear when a new Thalassemia Majors (Beta-Thalassemia Major) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.